Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Bladder Cancer”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Ended earlyNCT05712356
What this trial is testing

LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaGallbladder CancerGallbladder Carcinoma+5 more
Lisata Therapeutics, Inc. 66
Post-approval studies (Phase 4)Study completedNCT03174912
What this trial is testing

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Who this might be right for
Bladder CancerDisease ProgressionRecurrent Bladder Cancer
Ankara Training and Research Hospital 400
Not applicableUnknownNCT04298073
What this trial is testing

Skipping BCG for T1a Urinary Bladder Tumor.

Who this might be right for
Superficial Bladder Cancer t1a
Assiut University 43
Large-scale testing (Phase 3)WithdrawnNCT01284205
What this trial is testing

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Who this might be right for
Bladder Cancer
Bioniche Life Sciences Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT03652298
What this trial is testing

Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners

Who this might be right for
Colorectal CancerBladder CancerProstate Cancer+2 more
Centre Oscar Lambret 19
Not applicableNot Yet RecruitingNCT06982690
What this trial is testing

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

Who this might be right for
NMIBCTURBTBladder (Urothelial, Transitional Cell) Cancer+3 more
National Taiwan University Hospital 370
Testing effectiveness (Phase 2)Looking for participantsNCT06733363
What this trial is testing

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CarcinomaRecurrent Bladder CarcinomaRecurrent Non-Muscle Invasive Bladder Carcinoma+2 more
Roswell Park Cancer Institute 344
Not applicableStudy completedNCT04723121
What this trial is testing

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Who this might be right for
Bladder Cancer
Mansoura University 204
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableLooking for participantsNCT03973671
What this trial is testing

Prospective Sample Collection for Cancer of Bladder

Who this might be right for
Urinary Bladder Neoplasms
Universitaire Ziekenhuizen KU Leuven 300
Not applicableNot Yet RecruitingNCT07529639
What this trial is testing

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Who this might be right for
Urothelial Bladder CarcinomaBladder CarcinomaNon-Muscle-Invasive Bladder Cancer (NMIBC)+1 more
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Testing effectiveness (Phase 2)Study completedNCT01282463
What this trial is testing

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Who this might be right for
Carcinoma of Urinary TractUrethral CarcinomaCarcinoma of Ureter+1 more
Eli Lilly and Company 148
Large-scale testing (Phase 3)UnknownNCT00146276
What this trial is testing

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional Cell
Association of Urologic Oncology (AUO) 178
Not applicableUnknownNCT03121768
What this trial is testing

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
OncologyBladder CancerSuperficial Bladder Cancer+3 more
Mansoura University 761
Not applicableUnknownNCT03138824
What this trial is testing

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Who this might be right for
Bladder Urothelial CarcinomaTURBTBladder Neoplasm+1 more
Mansoura University 100
Testing effectiveness (Phase 2)Study completedNCT00088946
What this trial is testing

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
Jonsson Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT07106762
What this trial is testing

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Who this might be right for
Urothelial Cancer
Bristol-Myers Squibb 470
Load More Results